Sales Of Anticoagulant Is Expanding Over 2x To Be Valued At Us$ 65 Bn By The End Of The 2021-2031
Seoul, South Korea, 2022-Jul-19 — /EPR Network/ — Anticoagulants Market By Drug Class (Factor X Inhibitor (NOAC/DOAC) Anticoagulants, Heparin Anticoagulants, Direct Thrombin Inhibitor Anticoagulants, Vitamin [read full press release…]